COVID-19, asthma, and biological therapies: What we need to know

Managing patients with severe asthma during the coronavirus pandemic and COVID-19 is a challenge. Authorities and physicians are still learning how COVID-19 affects people with underlying diseases, and severe asthma is not an exception. Unless relevant data emerge that change our understanding of th...

Descripción completa

Detalles Bibliográficos
Autores principales: Morais-Almeida, Mário, Aguiar, Rita, Martin, Bryan, Ansotegui, Ignacio J., Ebisawa, Motohiro, Arruda, L. Karla, Caminati, Marco, Canonica, Giorgio Walter, Carr, Tara, Chupp, Geoffrey, Corren, Jonathan, Dávila, Ignacio, Park, Hae-Sim, Hanania, Nicola A., Rosenwasser, Lanny, Sánchez-Borges, Mario, Virchow, J. Christian, Yáñez, Anahí, Bernstein, Jonathan A., Caraballo, Luis, Chang, Yoon-Seok, Chikhladze, Manana, Fiocchi, Alessandro, González-Diaz, Sandra N., Tanno, Luciana Kase, Levin, Michael, Ortega-Martell, Jose António, Passalacqua, Giovanni, Peden, David B., Rouadi, Philip W., Sublett, James L., Wong, Gary W.K., Bleecker, Eugene R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: World Allergy Organization 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7229954/
https://www.ncbi.nlm.nih.gov/pubmed/32426090
http://dx.doi.org/10.1016/j.waojou.2020.100126

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7229954/
https://www.ncbi.nlm.nih.gov/pubmed/32426090
http://dx.doi.org/10.1016/j.waojou.2020.100126

Ejemplares similares